What is Lundbeck looking for
We are looking for projects and products that can strengthen our position as the leading company within psychiatry and neurology globally. Our strategy is to achieve this by actively supplementing our internal research and development efforts with external opportunities.
Lundbeck is interested in partnering opportunities which expand our range of pharmaceuticals for the treatment of brain diseases, including but not exclusive to:
- Alzheimer’s disease
- Parkinson’s disease
As a fully integrated pharmaceutical company, Lundbeck is active across all stages of a product’s life cycle. For external opportunities, we are interested in opportunities with a high level of innovation at the following stages:
- discovery projects
- pre-clinical projects
- early or mid-stage development projects
In order to develop new ground-breaking therapies, we are always interested in expanding our R&D capabilities by establishing R&D agreements with external parties.
Lundbeck are interested in expanding our business in all markets. We are a company that operates on all markets globally and we are expanding our business in many markets – including the US, China, Japan, Latin America and Asia in general.